Table 1.
Patients characteristics.
| Variables | Subjects (n = 67) |
|---|---|
| Age (years) | 73.6 ± 8.1 |
| Gender (male/female) | 50/17 |
| Body mass index (kg/m2) | 22.4 ± 2.5 |
| Comorbidities | |
| Smoking history | 51 (76.1%) |
| Hypertension | 56 (83.6%) |
| Dyslipidemia | 38 (56.7%) |
| Coronary artery disease | 19 (28.4%) |
| Cerebrovascular disease | 10 (14.9%) |
| Chronic kidney disease | 16 (23.9%) |
| Diabetes mellitus | 38 (56.7%) |
| Medications | |
| Nitroglycerin | 2 (3.0%) |
| β-Blocker | 13 (19.4%) |
| ACE-I | 7 (10.4%) |
| ARB | 37 (55.2%) |
| Statin | 32 (47.8%) |
| Hemodynamical parameters | |
| Ankle brachial pressure index | 0.85 ± 0.18 |
| Reactive hyperemia index | 1.61 ± 0.51 |
| Laboratory findings | |
| White blood cell (/μL) | 6605 ± 1558 |
| Hemoglobin (g/dL) | 13.5 ± 1.9 |
| Platelet (×104/μL) | 22.6 ± 4.9 |
| Prothrombin time (%) | 99.6 ± 14.8 |
| Activated partial thromboplastin time (sec) | 29.7 ± 3.8 |
| Fibrinogen (mg/dL) | 323.1 ± 63.1 |
| Albumin (g/dL) | 4.02 ± 0.39 |
| Creatinine (mg/dL) | 1.07 ± 0.54 |
| Total cholesterol (mg/dL) | 191.9 ± 39.8 |
| Triglycerides (mg/dL) | 135.1 ± 123.2 |
| High-density lipoprotein (mg/dL) | 62.5 ± 22.6 |
| Low-density lipoprotein (mg/dL) | 110.2 ± 24.8 |
| Hemoglobin A1c (%) | 6.38 ± 0.74 |
| C-reactive protein (mg/dL) | 0.27 ± 0.48 |
ACE-I, angiotensin converting enzyme-inhibitor; ARB, angiotensin II receptor blocker.